- Lab-On-A-Chips
- PDMS Lab-On-A-Chip
- Thermo Polymers Lab-On-A-Chip
- Glass LAB-ON-A-CHIP
- Silicon Lab-On-A-Chip
- Paper Lab-On-A-Chip
- Microarrays
- DNA Microarrays
- Tissue Microarrays
- Protein Microarray
- Others
Lab On-Chip And Microarrays Market size was valued at USD 15.81 billion in 2022 and is poised to grow at a significant CAGR of 13.6% from 2023-2029. Lab on the chip an evolutionary device which integrates single or many laboratory functions on one integrated circuit commonly, a cSizhip. Lab-on-chip generally measures about few square centimetres and used to achieve automation and high through screening. The microarray is the most recent advances in the cancer research. Microarrays help to analyse plenty of samples which have already been recorded or new samples, it even helps to test the incidence of a particular marker in tutors. There are two types of microarrays, gene expression microarrays and tissue microarrays. The lab on-chip and microarrays market has very few and dominant players who are actively participating in research and development of the new products. Companies are launching the new products to increase the market share.
Lab On-Chip And Microarrays Market Key Developments:
- In November 2016, Abbott laboratories received CE mark for its innovative blood testing device i-STAT Alinity point of care system, a portable device that can perform and analyse largest menu of blood tests on a single device. Furthermore, companies are collaborating in the development of the new products.
- In March 2016, CombiMatrix Molecular Diagnostics (CMDX) and Array Genomics Inc. entered into the collaboration agreement to develop and market a series of comparative genomic hybridization (CGH) microarray products.
Lab On Chip And Microarrays Market Summary
Study Period
2023-29
Base Year
2022
CAGR
13.6%
Largest Market
North America
Fastest Growing Market
Europe
Lab On Chip And Microarrays Market Dynamics
Global lab on chip and microarrays market is mainly driven by the increase in the adaptation of lab on chip and microarrays in various research fields such as drug discovery, genomics, proteomics and others. In addition, increase in demand for personalized medicine and increase in prevalence rates of cancer that led to the demand for the development of R&D related to cancer diagnostics and treatment expected to boost the global lab on chip and microarrays market over the forecast period. However, a high cost of devices and stringent regulations for research on genomes are expected to hamper the market growth over the forecast period.
North-America Got Significant Share
Lab On Chip And Microarrays Market Regional Analysis
Geographically global Lab On-Chip and Microarrays is segmented as Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America expected to contribute major growth in global lab-on-chip and microarrays market owing to increase in research and development activities related to cancer and gene sequencing technologies and increase in an adaptation of microarray and lab-on-chip products for diagnosis. Europe is expected to be another major market owing to rising cancer prevalence that leading to the need for the development of reliable and fast diagnostics. Asia Pacific is expected to grow at significant rates owing to the low cost of raw materials and developing healthcare infrastructure.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The lab-on-chip and microarrays market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Lab On Chip And Microarrays Market Segmentation
By Product Type
By End User
- Biotechnology and Pharmaceutical Firms
- Academic and Research Institutions
- Hospitals and Diagnostic Centres
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Frequently Asked Questions
The Lab on-chip and microarrays market size was valued at USD 15.81 billion in 2022
The key segments covered in the lab on-chip and microarrays market are technology, components, application, and end-users.
The Lab on-chip and microarrays market key players are Affymetrix Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Biomerieux SA (France), Beckman Coulter Inc. (U.S.), CombiMatrix Molecular Diagnostics (CombiMatrix Corp.) (U.S.)
| 1.Executive Summary |
| 2.Global Lab On-Chip And Microarrays Market Introduction |
| 2.1.Global Lab On-Chip And Microarrays Market - Taxonomy |
| 2.2.Global Lab On-Chip And Microarrays Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.End User |
| 2.2.3.Region |
| 3.Global Lab On-Chip And Microarrays Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Lab On-Chip And Microarrays Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Lab On-Chip And Microarrays Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Lab-On-A-Chips |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Microarrays |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Lab On-Chip And Microarrays Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Biotechnology and Pharmaceutical Firms |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Academic and Research Institutions |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Hospitals and Diagnostic Centres |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Lab On-Chip And Microarrays Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Lab On-Chip And Microarrays Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Lab-On-A-Chips |
| 8.1.2.Microarrays |
| 8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Biotechnology and Pharmaceutical Firms |
| 8.2.2.Academic and Research Institutions |
| 8.2.3.Hospitals and Diagnostic Centres |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Lab On-Chip And Microarrays Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Lab-On-A-Chips |
| 9.1.2.Microarrays |
| 9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Biotechnology and Pharmaceutical Firms |
| 9.2.2.Academic and Research Institutions |
| 9.2.3.Hospitals and Diagnostic Centres |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Lab On-Chip And Microarrays Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Lab-On-A-Chips |
| 10.1.2.Microarrays |
| 10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Biotechnology and Pharmaceutical Firms |
| 10.2.2.Academic and Research Institutions |
| 10.2.3.Hospitals and Diagnostic Centres |
| 10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Lab On-Chip And Microarrays Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Lab-On-A-Chips |
| 11.1.2.Microarrays |
| 11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Biotechnology and Pharmaceutical Firms |
| 11.2.2.Academic and Research Institutions |
| 11.2.3.Hospitals and Diagnostic Centres |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Lab On-Chip And Microarrays Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Lab-On-A-Chips |
| 12.1.2.Microarrays |
| 12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Biotechnology and Pharmaceutical Firms |
| 12.2.2.Academic and Research Institutions |
| 12.2.3.Hospitals and Diagnostic Centres |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Affymetrix Inc. (U.S) |
| 13.2.2.Abbott Laboratories (U.S) |
| 13.2.3.Agilent Technologies (U.S) |
| 13.2.4.Biomerieux SA (France) |
| 13.2.5.Beckman Coulter Inc. (U.S) |
| 13.2.6.CombiMatrix Molecular Diagnostics (CombiMatrix Corp) (U.S) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Affymetrix Inc. (U.S)
- Abbott Laboratories (U.S)
- Agilent Technologies (U.S)
- Biomerieux SA (France)
- Beckman Coulter Inc. (U.S)
- CombiMatrix Molecular Diagnostics (CombiMatrix Corp) (U.S)